Corporate ActionOct 15, 2026, 09:41 PM
City Therapeutics Files S-1MEF to Increase Share Offering by 1.6M Shares
AI Summary
City Therapeutics, Inc. has filed a Form S-1MEF, a post-effective amendment to its existing registration statement (File No. 333-299117). This filing is for the purpose of increasing the number of shares of common stock offered to the public by an additional 1,597,222 shares, including an underwriter option for 208,333 shares. This increase does not exceed 20% of the original offering price. The prior registration statement was declared effective on October 15, 2026.
Key Highlights
- City Therapeutics, Inc. is filing an S-1MEF to increase the number of shares offered.
- The company is registering an additional 1,597,222 shares of common stock.
- This includes an option for underwriters to purchase an additional 208,333 shares.
- The additional shares represent no more than 20% of the maximum aggregate offering price from the prior registration statement.
- The prior registration statement (File No. 333-299117) was declared effective on October 15, 2026.
Price Impact